OTC •
Healthcare •
Diagnostics & Research •
Quote as of 06/18/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeOTC
Market Capitalization9,120.21 mln
Float40.29 mln
Earnings Date09/04/2026
EPS
3.85
Solid
P / E
20.26
Premium valuation
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.88
Likely reliable
Relative Strength
32
/ 100
Underperforming
Debt / Equity
0.11
Very low leverage
Business Description
Founded in 1963 and headquartered near Lyon, France, bioMérieux is a global leader in medical diagnostics, helping clinicians and laboratories detect infectious diseases and identify harmful microorganisms quickly and accurately. The company serves both healthcare providers and industrial clients, offering a broad range of testing systems, instruments, software, and reagents used across hospitals, food production facilities, and research settings worldwide. Operating in over 160 countries, bioMérieux functions as a subsidiary of Institut Mérieux and remains focused on advancing patient care and public health through faster, more reliable diagnostic results.
